Navigation Links
'Health Courts' Critic to be Featured Speaker at Wyoming Patient Safety Panel
Date:10/12/2007

Co-Author of New Report, Medical Injustice, Will Challenge Corporate-Backed Proponents of "Health Courts"

WASHINGTON, Oct. 12 /PRNewswire-USNewswire/ -- Case Western University professor Dale Nance, co-author of the groundbreaking new report on health courts, Medical Injustice, will be one of the featured speakers at a patient safety forum in Cheyenne, Wyoming on Monday, October 15. The forum will debate the merits and weaknesses of the health courts concept.

Mr. Nance's report, written with fellow professor Max Mehlman under a grant from the American Association for Justice Robert L. Habush Endowment, found that health courts would require the creation of new and costly bureaucracies that would be controlled at every level by the insurance industry.

For more information, see the full Executive Summary at http://www.atla.org/pressroom/PressReleases/ExecutiveSummary.pdf .

View the Health Courts fact sheet at http://www.atla.org/pressroom/PressReleases/HealthCourts.doc.

The report found many critical flaws in the health courts concept,

including:

-- The new health courts bureaucracies would place a massive financial

burden on taxpayers and the employers and employees that pay for

health care insurance.

-- The decision making process would be controlled at every stage by the

insurance industry.

-- A health courts bureaucracy would not be affordable without

substantial increases in doctors' malpractice premiums.

-- Patients would be forced into the bureaucracies without any choice,

and many claims would be arbitrarily limited or barred altogether.

-- Patients would have to prove the "avoidability" of their injuries and

even those successful in their claim w
'/>"/>

SOURCE American Association for Justice
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Poor health care in Russia maybe causing Decline in its Population
2. Startling Expose – Physicians Often Have No Regular Source Of Health Car
3. Debate Rages over firing of HIV infected health care workers
4. Want a Healthy brew? Have some Tea!
5. Patient’s perception of health status helps in better recover
6. Antioxidants protect health tissue in people undergoing radiation therapy.
7. Sexual abuse affect health for a lifetime
8. Smoking a greater risk than HIV? Yes say health experts!!!!
9. Healthcare sector is now a multi billion-dollar industry in India
10. Exclusive breast-feeding advised for six months in infants recommends World Health Organization
11. How much can exercise improve health?
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2008)... Mich., Aug. 29 /PRNewswire/ -- In response to rec... chronic wasting disease (CWD),members of the dee...ement., With hunting season fast approaching, the... a deer on a Kent County farm understandably has,c...and deer farmers across,the great state of Michiga...
(Date:8/29/2008)...esults of a 10-year study published in the August ...found that magnesium sulfate administered to women...he risk of cerebral palsy by 50 percent. The Benef...) trial was conducted in 18 centers in the U.S., i...renatal intervention ever found to reduce the inst...
(Date:8/29/2008)... Trusted life science software provid...ents to engage via GSA. , ...ns, an emerging software engineering firm dedicat...U.S. General Services Administration (GSA) Contrac...omers with the ability to conveniently engage 5AM ...
(Date:8/28/2008)... will lead clinical efforts of the Maryland Medica.../ -- KePRO, a national medical,management firm, ap...of,Medical Director. Dr. Lawyer will oversee all c...rmed in KePRO,s Hunt Valley, Maryland Harrisburg,o...cal career in Maryland," said,Alice Stollenwerk Pe...
Breaking Medicine News(10 mins):Health News:Deer Farm Industry in Michigan Issues Statement on the Recent Chronic Wasting Disease Case Identified on a Kent County Deer Farm 2Health News:National study shows magensium sulfate reduces risk of cerebral palsy in premature births 2Health News:Federal and State Agencies Have Easier Access to 5AM Solutions' Award-Winning Software Services 2Health News:Lenaye Lawyer, MD, FACOG, Named KePRO Medical Director 2
...er retinoblastoma has been developed by scientists...nstrated// in a mouse model to cause a remarkable ...g the side effects common with standard chemothera...suitable for certain forms of breast, lung, prosta...
...ive pulmonary disease (COPD) attempt to repair dam...s finding is in contradiction with the convention...he finding is important because it could pave the ...on' key genes to allow the lung to grow new alveol...
...haviors of human beings has found that concerns ov...are unfounded.// Monogamy is still held in esteem ...y are published in The Lancet. The research has g...ch found that people were in single relationships ...
... tackled by more action and less talk according to...ter// voiced support for higher taxes on drinks. ...cottish Health Action on Alcohol Problems (SHAAP) ...alth problems and push for action to cut alcohol m...
Other Medicine News:Health News:Revolutionary Eye Cancer Treatment 2Health News:Revolutionary Eye Cancer Treatment 3Health News:Revolutionary Eye Cancer Treatment 4Health News:Lungs repair themselves 2Health News:Alcohol Abuse Must be solved with Action 2
(Date:8/27/2008)...ust 27 /-, - Oralair(R) Gr...Pharmacodynamic Study Conducted in an Allergen Cha...ighly positive results of a new study,conducted in...on Oralair(R) Grasses included 86 adult patients e...eatment durations: 1 week, 1 month,2 and 4 months...
(Date:8/26/2008)...6 /- The Oregon Tourism Commission,la...ervice Training Program,(Q Care) this week on htt...ining program created to support the tourism and,h...ation. By emphasizing,the importance of quality cu...with tools and resources to better serve Oregon,s ...
(Date:8/26/2008)...26 /- Semafore Pharmaceuticals Inc.,p...s on Targeted Therapies,in Cancer in Washington, D...ted kinase inhibitors that demonstrate significant...ovel and proprietary molecular scaffold has been d... the design of pan-PI3 kinase inhibitors,as well a...
(Date:8/26/2008)... 26 /- Cambridge Research &,Instrumen...estro(TM) EX In,Vivo Imaging System. The new syste...ogy and becomes the entry-level instrument of choi...tp://www.newscom.com/cgi-bin/prnh/20080826/NETU054...ancement of CRi,s unique,solid-state tunable optic...
Breaking Medicine Technology:Stallergenes: New Study VO 56 Highly Positive Results Conducted in an Allergen Challenge Chamber 2Stallergenes: New Study VO 56 Highly Positive Results Conducted in an Allergen Challenge Chamber 3Oregon Tourism Commission Unveils New Online Customer Service Training Program 2Semafore Broadens Pipeline With Multi-Targeted Kinase Inhibitors 2Semafore Broadens Pipeline With Multi-Targeted Kinase Inhibitors 3CRi Announces New Maestro(TM) EX In Vivo Imaging System with Improved Performance and an Affordable Price 2Hormonal Changes and Depression 3A What is the Connection 3F 6212 1Hormonal Changes and Depression 3A What is the Connection 3F 6212 2Hormonal Changes and Depression 3A What is the Connection 3F 6212 3Hormonal Changes and Depression 3A What is the Connection 3F 6212 4Telomerase enzyme structure provides significant new target for anti cancer therapies 6207 1Telomerase enzyme structure provides significant new target for anti cancer therapies 6207 2Telomerase enzyme structure provides significant new target for anti cancer therapies 6207 363 percent of diabetics risk serious foot problems by wearing the wrong sized shoes 6202 163 percent of diabetics risk serious foot problems by wearing the wrong sized shoes 6202 2How much fish have we got 3F 1202 1How much fish have we got 3F 1202 2How much fish have we got 3F 1202 3
...- Data from Phase III pivotal trial demonstrate sa...formoterol fumarate for,patients with moderate to ...wire/ -- Dey, L.P. announced,that two clinical dat... Conference of the American Thoracic Society (ATS)...rancisco. The,presentations will detail Phase III ...
...HITEHOUSE STATION, N.J.--(BUSINESS WIRE)--May 17, ...how that Merck,s cervical cancer,vaccine, GARDASIL...16, 18) Recombinant Vaccine) was 100 percent effec...ysplasias caused by HPV,types 16 and 18, two types...percent protection was observed in women who were ...
Other Medicine Technology:Clinical Trial Data for Perforomist Inhalation Solution to be,Presented at ATS on May 20, 2007 2Clinical Trial Data for Perforomist Inhalation Solution to be,Presented at ATS on May 20, 2007 3Clinical Trial Data for Perforomist Inhalation Solution to be,Presented at ATS on May 20, 2007 4Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 2Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 3Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 4Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 5Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 6Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 7Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 8Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 9Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 10Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 11Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 12Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 13Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 14Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 15Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 16Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 17Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 18Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 19Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 20Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 21Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 22Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 23Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 24Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 25Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 26Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 27Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 28Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 29Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 30Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 31Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 32
The Soft-Touch Timeter® Flowmeter is durable, long-lasting and easy to maintain. Timeter ® by Allied Flowmeters: Quality Plus Value.
Amvex offers a complete line of flowmeters, available in oxygen, air, heliox and CO 2 . They are all available in a variety of calibrations to best suit your application. With color coded labels and
Amvex offers a complete line of flowmeters, available in oxygen, air, heliox and CO 2 . They are all available in a variety of calibrations to best suit your application. With color coded labels and
Amvex offers a complete line of flowmeters, available in oxygen, air, heliox and CO 2 . They are all available in a variety of calibrations to best suit your application. With color coded labels and
Medicine Products: